Duane Barnes

This profile gathers the share dealings of Duane Barnes in Swedish Orphan Biovitrum AB (publ). The record holds 14 filings, for trades running from 4 June 2024 to 30 July 2026.

The open-market side counts 4 purchases for €5.8M alongside 7 sales for €11.6M. Sales outweigh purchases by €5.8M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 3 share grants. In 2026 alone, the filings show 1 purchase and 2 sales.

In size, the median ticket on the buying side is €1.8M. Clusters matter here: 3 out of 4 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

Most recently, on 30 July 2026, the filings show an open-market sale worth €4.2M in Swedish Orphan Biovitrum AB (publ). The latest purchase dates back some time: it was published 85 days ago, on 30 July 2026. The median gap between a trade and its publication by Finansinspektionen is 3 days. Under the Market Abuse Regulation, managers have three business days to notify their trades. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.